CT News and Research

RSS

Study examines how SARS CoV-2 aerosols travel through the lower lungs

When we inhale isolated coronavirus particles, more than 65% reach the deepest region of our lungs where damage to cells can lead to low blood oxygen levels, new research has discovered, and more of these aerosols reach the right lung than the left.

8 Jun 2021

Using AI to fight COVID-19

A study based in Taiwan and published in the Journal of Clinical Medicine focuses on the role of AI in managing COVID-19 through digital images, clinical and laboratory analysis such as screening and diagnosis.

7 Jun 2021

Risk of SARS-CoV-2 transmission aboard aircraft is low: A review of evidence

Researchers in Romania, the UK, and Canada have systematically reviewed the evidence available on the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) aboard aircraft.

7 Jun 2021

Using AI technology to predict the risk of coronary heart disease

A new project using artificial intelligence technology could spell a medical breakthrough for people suffering from, or at risk of, coronary artery disease, the single leading cause of death in Australia.

4 Jun 2021

New method gives an accurate real-time estimate of epidemic trajectories

A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.

3 Jun 2021

Long COVID patients at higher risk of small airway disease

The preprint discussed herein describes the effects of SARS-CoV-2 on lung structure and function in patients with long COVID.

2 Jun 2021

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.

2 Jun 2021

BMI may not be best obesity indicator to evaluate lung cancer risk, study suggests

New research published in the Journal of Thoracic Oncology suggests the method used to calculate how obesity is measured may affect whether it is considered a risk factor for lung cancer.

2 Jun 2021

Women who experience acute aortic dissection are more likely to die than men, shows study

Women who experience acute aortic dissection - a spontaneous and catastrophic tear in one of the body's main arteries - not only are older and have more advanced disease than men when they seek medical care, but they also are more likely to die, according to research published online today in The Annals of Thoracic Surgery.

2 Jun 2021

SARS-CoV-2 variants have higher transmissibility and a longer infectious period

Researchers analyzed data on three variants of concern and found that viral loads were higher and infection lasted longer for the B.1.1.7 variant. They all were more infectious than the original strain, and transmissibility also depended on population demographics.

31 May 2021

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

Corona Virus Disease (COVID -19) patients primarily appear with respiratory issues and viral pneumonia. The patients may also present cardiovascular issues includes early signs of acute myocardial injury.

29 May 2021

Researchers report key study results on duplex ultrasound for diagnosis of ICA stenosis

Online first in Vascular Medicine, researchers from the Intersocietal Accreditation Commission (IAC) Vascular Testing division report findings of their multi-centered study of duplex ultrasound for diagnosis of internal carotid artery (ICA) stenosis.

28 May 2021

Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study

A recent study by researchers in Singapore shows the absence of evidence for adverse effects on fertility or the presence of the vaccine mRNA (messenger ribonucleic acid) in breast milk, following the administration of the Pfizer BNT162B2 COVID-19 vaccine. This supports efforts to prevent the spread of false information about the effects of the vaccine.

27 May 2021

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

It is well known that the onset of the coronavirus disease 2019 (COVID-19) pandemic disrupted most non-essential healthcare services, including antenatal care. A new study from Belgium presents a snapshot of the experiences of midwives in that country during the months of May and June 2020.

27 May 2021

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

From Waters Corporation 27 May 2021

Tsimane's brains experience less brain atrophy than Westerners as they age, indicates study

A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers.

26 May 2021

SARS-CoV-2 UK variant may induce more inflammation, study suggests

Since COVID-19 was first detected in December 2019 in Wuhan, China, many different variants of its causative virus – SARS-CoV-2 – have emerged. Through increased viral fitness, some of these have risen to predominance over earlier variants in a remarkably short period of time. New research, by a team of scientists at major institutions in France, examines the reasons behind this phenomenon in one such variant of concern (VOC), the so-called UK variant.

25 May 2021

Pandemic leads doctors to rethink unnecessary treatment

Covid-19 is opening the door for researchers to address a problem that has vexed the medical community for decades: the overtreatment and unnecessary treatment of patients.

25 May 2021

DEFINE: Trial designed to test repurposed treatments in patients with COVID-19

A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.

25 May 2021

Could an antiviral mouthwash using silver nanoparticles prevent COVID-19?

In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.

24 May 2021

CT News and Research

Study examines how SARS CoV-2 aerosols travel through the lower lungs

Using AI to fight COVID-19

Risk of SARS-CoV-2 transmission aboard aircraft is low: A review of evidence

Using AI technology to predict the risk of coronary heart disease

New method gives an accurate real-time estimate of epidemic trajectories

Long COVID patients at higher risk of small airway disease

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

BMI may not be best obesity indicator to evaluate lung cancer risk, study suggests

Women who experience acute aortic dissection are more likely to die than men, shows study

SARS-CoV-2 variants have higher transmissibility and a longer infectious period

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

Researchers report key study results on duplex ultrasound for diagnosis of ICA stenosis

Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

Tsimane's brains experience less brain atrophy than Westerners as they age, indicates study

SARS-CoV-2 UK variant may induce more inflammation, study suggests

Pandemic leads doctors to rethink unnecessary treatment

DEFINE: Trial designed to test repurposed treatments in patients with COVID-19

Could an antiviral mouthwash using silver nanoparticles prevent COVID-19?

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News